Skip to main content
Caplight Logo









Carenation

Carenation

Private
SeoulHealthcare & Life Scienceshttps://carenation.kr/

Last Round

Series B

Extension

Jan 17, 2024

Est. Valuation

$75.19M

Total Funding Raised

$25.3M

Company Overview

Carenation is a healthcare technology company that operates an integrated care platform connecting patients with caregivers, including nursing assistants and postpartum helpers.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, E-commerce, Home & Lifestyle

Business Model

B2B2C

Customer Profile

Marketplace Commission, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

caregiver marketplacehome careelderly carecaregiving platformvisiting nursinghospital companionmedication managementmedical suppliescare matchingsilver techcare techdigital healthend-of-life planning

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carenation Comparables

Compare Carenation with similar companies based on industry and business-model similarity.

Carenation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bosalpim
85%
Caring
84%
Code Blossom
84%

Carenation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 17, 2024
DebtJul 6, 2022
Early FundingNov 25, 2021
Series AMar 24, 2020

Carenation Investors

Notable investors and investment history

Carenation investors
InvestorRounds
Hana VenturesSeries B Extension, Early Funding, Series A
DAYLI PartnersDebt
Saehan VenturesEarly Funding
Samsung Venture InvestmentSeries B Extension, Early Funding
ROWE PartnersSeed
HB InvestmentEarly Funding, Seed, Series A
LSK InvestmentEarly Funding, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2022

    $1.54M debt round led by DAYLI Partners.

  • Nov 25, 2021

    $14M raised from Samsung Venture Investment and others.

Carenation Filings

Explore SEC and related filing metadata, where available.

Carenation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Carenation's valuation, stock price, and market status.

Is Carenation a public or private company?

Carenation is a private company.

What is the current stock price of Carenation?

Carenation is a private company with no public stock price. No recent secondary market data is available.

How much is Carenation worth (valuation)?

Carenation's valuation is estimated at $75.2M based on funding round data.

Can I buy Carenation stock?

Carenation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Carenation's last funding round?

Carenation's most recent funding round was Series B Extension on January 17, 2024.

Who are the main investors in Carenation?

Key investors in Carenation include Hana Ventures, DAYLI Partners, Saehan Ventures, Samsung Venture Investment, ROWE Partners.

Will Carenation IPO soon?

No public IPO plans have been announced for Carenation.

How can I track Carenation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carenation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Year Founded2013
Last FundingJan 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?